Who is sponsoring NCT05022290?

NCT05022290 is sponsored by Khon Kaen University.

What drugs are being tested in NCT05022290?

Interventions in NCT05022290: Single-syringe diluted with normal saline technique.

What condition does NCT05022290 study?

NCT05022290 studies Supraventricular Tachycardia.

Is NCT05022290 still recruiting?

NCT05022290 is currently status unknown. Last updated 17 March 2023.

Last reviewed 2023-03-17 · How we verify

NCT05022290

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Double-syringe vs Single-syringe Technique of Adenosine for Termination of Regular Narrow Complex Tachycardia

Status unknown NA Last updated 17 March 2023

What this trial tests

NA trial testing Single-syringe diluted with normal saline technique in Supraventricular Tachycardia in 300 participants. Status unknown.

Timeline

1 October 2020

Primary endpoint
31 December 2024

30 June 2025

Quick facts

Lead sponsor	Khon Kaen University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	300
Start date	1 October 2020
Primary completion	31 December 2024
Estimated completion	30 June 2025
Sites	1 location across Thailand

Drugs / interventions tested

Single-syringe diluted with normal saline technique

Conditions studied

Supraventricular Tachycardia — all drugs for Supraventricular Tachycardia →

Sponsor

Khon Kaen University

Who can join

Adults 18 to 80, any sex, with Supraventricular Tachycardia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Adenosine has been discovered since 1929 and used in the acute treatment of arrhythmias. It uses as a therapeutic diagnosis in patients with regular narrow QRS complex tachyarrhythmias. The conventional method of adenosine administration is the double syringe technique (DST). However, it consumes a lot of resources including two syringes, a stopcock, an extension tube, and needs 2 nurses to administer. An observational study found that a single syringe technique (adenosine diluted with normal saline up to 20 ml) was as effective as a double syringe technique. However, there is no randomized control trial for proving its efficacy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Comparison between the double-syringe and the single-syringe techniques of adenosine administration for terminating supraventricular tachycardia: A pilot, randomized controlled trial.
Kotruchin P, Chaiyakhan IO, Kamonsri P, Chantapoh W, et al · · 2022 · cited 10× · PMID 35340059 · DOI 10.1002/clc.23820

Verify or expand the search:

Other recruiting trials for Supraventricular Tachycardia

Currently open trials in the same condition.

NCT07018648 — Clinical Safety and Efficacy Testing of a Medical Device Kardi Ai, an ECG Telemetry Monitoring System · NA · recruiting
NCT06087497 — The Z Stitch Early Bed Rest Assessment Study · NA · recruiting
NCT05521451 — Clinical Cohort Study - TRUST · recruiting

Other Khon Kaen University trials

Trials by the same sponsor.

NCT07494396 — An AI-Based Erythema Measurement System for Psoriasis Lesions · not yet recruiting
NCT07054775 — Comparison of Pruritus Incidence After Intrathecal Morphine 0.1 vs 0.2 mg in Cesarean Section · Phase 4 · recruiting
NCT06994520 — Efficacy of Topical Cannabidiol for Eczema · Phase 2 · active not recruiting
NCT06958029 — Postoperative Atrial Fibrillation in Cardiac Surgery · recruiting
NCT06289257 — Analysis of Vitamin D and VDR Expression in Endometriosis: A Case-Control Study · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05022290 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Khon Kaen University
Last refreshed: 17 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05022290.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing